Skip to main content
. 2019 Feb 13;10(2):139. doi: 10.1038/s41419-019-1314-x

Fig. 3. Met tyrosine kinase inhibitors (Met-TKIs) induced autophagy via Met/mTOR/ULK1 signaling pathway.

Fig. 3

ad Gastric cancer (GC) cell lysates were immunoblotted for indicated proteins after exposure to Met-TKIs (PHA-665752 (PHA) 200/600 nM, SU11274 (SU) 1/0.8 μM, crizotinib (Criz) 100/50 nM or volitinib (Voli) 10/4 nM for MKN45 and SNU5 cells, respectively) or starvation by serum-free medium with/without hepatocyte growth factor (HGF; 50 ng/ml for 30 min) or mammalian target of rapamycin (mTOR) agonist MHY1485 (MHY; 5 μM) for 36 h